Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Toschi

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Stroke|September 10, 1998
High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined causeV Toschi, A Motta, C Castelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Lipoprotein (a) and fibrinolytic system in liver cirrhosis. Coagulation Abnormalities in Liver Cirrhosis (CALC) Study GroupC Cimminiello, M Soncini, M C Gerosa, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterizationM Biancardi, C Cimminiello, V Toschi, et al.
Angiology|December 1, 1994
Plasma levels of tumor necrosis factor and endothelial response in patients with chronic arterial obstructive disease or Raynaud's phenomenonC Cimminiello, G Arpaia, V Toschi, et al.
Acta Haematologica|January 1, 1991
Clinical significance of endothelial damage markers in essential mixed cryoglobulinemiaV Toschi, G F Fiorini, A Motta, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1992
Structural and functional characterization of plasma fibronectin in patients with essential mixed cryoglobulinaemiaV Toschi, G F Fiorini, A Motta, et al.
Haemostasis|September 1, 1993
Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosusV Toschi, A Motta, C Castelli, et al.
Circulation|April 13, 1999
Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditionsJ J Badimon, M Lettino, V Toschi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterolC Cimminiello, P Vigorelli, T Piliego, et al.
The Mount Sinai Journal of Medicine, New York|September 1, 1995
Evolving concepts in the pathogenesis and treatment of arterial thrombosisJ H Chesebro, V Toschi, M Lettino, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Stroke|September 10, 1998
High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined causeV Toschi, A Motta, C Castelli, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Lipoprotein (a) and fibrinolytic system in liver cirrhosis. Coagulation Abnormalities in Liver Cirrhosis (CALC) Study GroupC Cimminiello, M Soncini, M C Gerosa, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterizationM Biancardi, C Cimminiello, V Toschi, et al.
Angiology|December 1, 1994
Plasma levels of tumor necrosis factor and endothelial response in patients with chronic arterial obstructive disease or Raynaud's phenomenonC Cimminiello, G Arpaia, V Toschi, et al.
Acta Haematologica|January 1, 1991
Clinical significance of endothelial damage markers in essential mixed cryoglobulinemiaV Toschi, G F Fiorini, A Motta, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1992
Structural and functional characterization of plasma fibronectin in patients with essential mixed cryoglobulinaemiaV Toschi, G F Fiorini, A Motta, et al.
Haemostasis|September 1, 1993
Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosusV Toschi, A Motta, C Castelli, et al.
Circulation|April 13, 1999
Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditionsJ J Badimon, M Lettino, V Toschi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1997
Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterolC Cimminiello, P Vigorelli, T Piliego, et al.
The Mount Sinai Journal of Medicine, New York|September 1, 1995
Evolving concepts in the pathogenesis and treatment of arterial thrombosisJ H Chesebro, V Toschi, M Lettino, et al.
Pageof 4